{"disease":{"id":"response-evaluation","name":"response evaluation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05763277","title":"Ate-Bev Early Response Prediction Model in Advanced HCC","phase":"","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03616951","title":"Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"University of Aarhus","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}